JLM-BioCity is working hard to connect every bio-professional and company in the Jerusalem area for you. This is the most comprehensive list of companies and potential collaborators in Jerusalem.
Feel free to use it to find your next partner, employee, investor, lawyer in your field.
Feel free to use our Facebook Group or ask us to introduce you with any of them.
Are you part of us? If not, we encourage you to join us.
BioMed
NIMD Ltd
Brainsway
HIL Applied Medical Ltd.
Medinol Ltd.
Novamed Ltd.
-
NIMD Ltd
Anan Copty, CEO
Stage: (early, R&D, clinical (trials) ,advanced, mature): R&D (Pre-Clinical)
Year Established: 2015
NIMD (NoneInvasive Medical Devices) is an innovative medical device startup company at the pre-clinical stage that is focused on the treatment of cancer. The company is seeking funding for Round A and is also looking for strategic partnerships. The technology is based on an ablative device that utilizes a noninvasive localized microwave radiation device combined with FDA approved nanoparticles that are injected into the tumors. Using this technology we are able to heat and destroy tumors without damaging the surrounding healthy tissue. The device can also detect tumors at an early stage.
26 Yaakov Shreibom Street, Ramat Beit Hakerem, Jerusalem 9103501 Israel
-
Brainsway
Guy Ezekiel Pres. & CEO
Est: 2003
Stage: Mature
Brainsway's Deep TMS is FDA cleared for treating depressive episodes in adult patients suffering from Major Depressive Disorder and in clinical trials for other neuropsychiatric and neuroscience applications.
19 Hartum St.Bynet Bldg, 3rd floor, Har Hotzvim
-
HIL Applied Medical Ltd.
Sagi Brink-Danan CEO
Est: 2010
Stage: R&D
HIL is developing a new class of ultra-compact, high-performance cancer Proton Therapy systems
Hi-Tech Park 4/5, Givat Ram, Jerusalem, Israel
-
Medinol Ltd.
Dr. Judith Richter Founder & CEO
Est: 1992
Stage: Advanced
Medinol is dedicated to the science of cardiovascular intervention. Medinol develops, manufactures, and markets the industry-leading NIRxcell™ Bare Metal Stent (BMS). Made from thin cobalt-chrome alloy and recognized for its unique flexibility, conformability and scaffolding.
Building 8, 35th Floor, Kiriyat Atidim, POB 58165 Tel Aviv 6158101 ISRAEL
-
Novamed Ltd.
Dr. Emil Katz CEO
Est: 1995
Stage: Advanced
Novamed, Ltd. is a privately owned Israeli life science company. Novamed has been committed to the development of innovative, proprietary diagnostic systems with worldwide marketing potential.
28 Pierre Köenig St., Talpiot Industrial Area POB 5323, Jerusalem 91531 Israel
BioTech
RenalSense
CellCure Neurosciences Ltd.
Gamida Cell LTD.
KoVax Ltd.
Alomone Labs Ltd.
NovellusDx Ltd.
-
RenalSense
Avi Kleiman CEO and Co-Founder
Stage: (early, R&D, clinical (trials) ,advanced, mature) Mature
Year Established 2010
RenalSense is a medical device company dedicated to real-time renal diagnostics. Its flagship product, Clarity RMS, changes the practice of ICU and critical care management by providing continuous, automatic monitoring of urine flow. This facilitates early detection of changes in renal function and the risk of Acute Kidney Injury (AKI) - enabling rapid intervention, better patient care, and improved ICU economics.
3 Hamarpe, Har Hotzvim, Jerusalem, Israel 914501
-
CellCure Neurosciences Ltd.
Charles Irving CEO
Est: 2005
Stage: Advanced
Cell Cure Neurosciences is focused on developing cell therapies for retinal and neural degenerative disease.
P.O.B 12247, Jerusalem 91121
-
Gamida Cell LTD.
Yael Margolin Pres. & CEO
Est: 1998
Stage: Advanced
Gamida Cell LTD. develops novel curative treatments for orphan hematological diseases and malignancies using stem cells and Natural Killer cells.
P.O Box 34670, Jerusalem 91340 Israel
-
KoVax Ltd.
Orit Kotler Co-Founder. & CEO
Est: 2003
Stage: Advanced
KoVax Ltd – Specializes in Aqua culture vaccines development and manufacturing. Our objective is to ensure fish health all over the world. We conduct research that facilitates the development of effective vaccines in the Aqua culture world and we provide our customer’s diagnostic services in all fish grow stages..
The company manufactures and is the patent owner of KV3 vaccine (with marker) against CyHV3 (KHV) for KOI and Common Carp. -
Alomone Labs Ltd.
Nissim Bajayo & CEO
Est: 1989
Stage: Advanced
Alomone Labs, leader in ion channel research, supplier of validated Ion Channel, GPCR and Neural Signaling tools. Production of primary antibodies, small molecules, proteins and peptides. .
Jerusalem BioPark (JBP), Hadassah Ein Kerem, P.O. Box 4287 Jerusalem 9104201, Israel
-
NovellusDx Ltd.
Haim Gil-Ad Co-Founder & CEO
Est: 2011
Stage: R&D
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient.
NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
Jerusalem Bio-Park 5th floor. Hadassah Medical Center Campus, P.O.B 12057 Jerusalem, 91120, Israel
Pharma
Lipomedix Pharmaceutical Ltd.
Pepticom Ltd.
Raziel Therapuetics Ltd.
Immunovative Therapies
Immunovative Therapies
Intec Pharma Ltd.
Izun Pharma Ltd.
Oramed Pharmaceuticals Inc.
Rafa Laboratories Ltd.
Silenseed Ltd.
BioCancell Therapeutics Israel Ltd.
-
Lipomedix Pharmaceutical Ltd.
Alberto Gabizon, CEO
Stage: (early, R&D, clinical (trials) ,advanced, mature) Clinical stage
Year Established: 2011
LipoMedix is a clinical-stage privately held company focused on the development of an innovative, safe and effective cancer therapy based on liposome delivery. LipoMedix’s lead product Promitil® is a pegylated liposomal carrier for a known pro-drug of the chemotherapy agent Mitomycin C.
Givat Ram Hi-Tech Park, POB 39262, Jerusalem
-
Pepticom Ltd.
Immanuel Lerner CEO
Est:2011
Stage: Mature
Pepticom Ltd. developed exceptional computational software, which allows for the design of peptides that bind a target protein, to develop novel or to optimize drugs.
Malha Technology Park (GATI), Building 8, 3rd floor, Jerusalem, Israel
-
Raziel Therapuetics Ltd.
Alon Bloomenfeld CEO
Est:20120
Stage: Advanced
Proprietary compound that converts WAT (White Adipose Tissue) to BAT (Brown Adipose Tissue) to treat overweight & obese patients..
-
Immunovative Therapies
Phillip Schwartz CEO & Founder
Est:2010
Stage: R&D
Entera Bio develops oral drug delivery by utilizing its proprietary innovative technology which protects large molecules and peptides in the GI tract.
-
Immunovative Therapies
DR. MICHAEL HAR-NOY CEO & Founder
Est:2004
Stage: Advanced
Driven by compassion for patients suffering from incurable disease or highly toxic therapies, our mission is to develop innovative biological drug products and treatment protocols which harness the power of the human immune system to provide patients with cost effective improved quality of life and curative or life-extending treatment options.
Malcha Technology Park, 1 Agudat Sport Hapoel Street, Jerusalem, 96951, Israel
-
Intec Pharma Ltd.
Giora Carni, Chairman of the Board. Zeev Weiss CEO
Est:2000
Stage: Advanced
Intec Pharma is a drug development company, applying its innovative proprietary gastric retention technology to develop improved formulations of drugs.
12 Hartom st. (RMPE building) P.O.Box 45219, Jerusalem 91450 Israel
-
Izun Pharma Ltd.
William Z. Levine Chairman & Jack Talley CEO
Est:2000
Stage: Advanced
Izun Pharmaceuticals is dedicated to harnessing nature’s complexity through the use of modern science to create and optimize botanical pharmaceutical products for the consumer health care industry.
Hi-Tech Park 2/4 Givat Ram, P.O Box 39098 Jerusalem, 91390, Israel
-
Oramed Pharmaceuticals Inc.
Nadav Kidron Co-Founder & CEO
Est:2006
Stage: R&D
Oramed Pharmaceuticals has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection
Hi-Tech Park 2/4 Givat Ram, P.O Box 39098 Jerusalem, 91390, Israel
-
Rafa Laboratories Ltd.
Yaron Zakhyem Genral Manager & CEO
Est:1958
Stage: Advanced
Rafa is a pharmaceutical company in Israel that markets, manufactures and distributes prescription (Rx) and over-the-counter (OTC) medicines, mainly proprietary formulations, as well as generic formulations, and consumer health products.
Factory: Zeev Lev 3, Har Hotzvim, Jerusalem
-
Silenseed Ltd.
Dr Amotz Shemi Co-Founder & EO
Est:2008
Stage: Advanced
Silenseed LTD is a clinical stage biopharmaceutical company that is developing proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors.
2 HaMa’ayan Street, Modi’in Technology Park Modi’in 7177871, Israel
-
BioCancell Therapeutics Israel Ltd.
Jonathan Burgin CEO
Est:2004
Stage: Clinical
BioCancell is focused on the discovery, development and commercialization of novel therapies to treat cancer-related diseases. Its most advanced product candidate, BC-819, is under development as a treatment for non-muscle-invasive bladder cancer (NMIBC)
1/3 High-Tech Village, Givat Ram, Jerusalem, Israel PO Box 39264, Jerusalem 9139102, Israel
E-Health
Archi Medics Global Group-mymdband
-
Archi Medics Global Group-mymdband
Co founders: Elly Gorodetzer & Gidon Rogers
Stage: (early, R&D, clinical (trials) ,advanced, mature) Advanced
Year Established: 2013
MyMDband is a unique emergency focused EMR (coined e-EMR) comprised of a secure cloud server and individual QR coded bracelets. MyMDband is the ultimate solution for providing the emergency medical team, critical historical medical, at the location of the medical event, all in the EMT's spoken language.
Jerusalem
